10A - The Michigan Daily - Thursday, February 13, 2003

Work starting
to pay dues for
Henderson
By Dan Rosen
Daily Sports Writer
Michigan forward Charlie Henderson has skated at Michi-
gan State's Munn Ice Arena dozens of times. But the East
Lansing native has never come out of the tunnel wearing
maize and blue. He's never absorbed the harassment of the
Spartan faithful. And he can't wait to do it.
"I've always dreamed about playing at Munn' Henderson,
whose uncle is the rink manager there, said. "Ever since I
came here, I've been looking forward to the date that I play
against (Michigan State) there."
Last year, the Wolverines faced the Spartans in the historic
"Cold War" outdoors at Spartan Stadium. As a result, Hen-
derson hasn't had a chance to play at Michigan State's home
ice arena as a Wolverine. He is hoping that this will be his
chance.
It's been a frustrating year thus far for the sophomore. After
walking on as a freshman, Henderson earned a spot as a regu-
lar in the lineup over the second half of last season and he
took advantage, notching 13 points and seven goals.
But things haven't gone the way he would have hoped yet
this year. All season, Henderson has been struggling to earn
the playing time that he used to get consistently. He has
dressed in just 12 of 28 games so far this season.
"He had a good year last year," associate coach Mel Pear-
son said. "He scored some big goals for us in the second half,
so he's capable. Unfortunately this year, there have just been
some people who have probably played better than he has."
For Henderson, that's been tough to swallow.
"It's been really difficult for me," Henderson said. "Last
year, I got accustomed to playing all the time and (I got in) a
groove. This year it's just a little bit tougher to find a groove
and to keep that confidence going that I had last year. But
you've got to just keep working hard, and if you keep working
hard good things will happen."
His efforts are starting to pay off.
Last weekend against Northern Michigan, Henderson
returned to the lineup and provided a spark for the Wolver-
ines. He didn't score a goal, but Henderson's play still drew
rave reviews from coaches and teammates.
"Charlie, I thought, came in and played really well this

Big Ten
By Eric Chan
Daily Sports Writer
The Big 12? PAC-10? ACC? Su
powerhouses in basketball and foot
wrestling, the Big Ten has always
only getting better.
With teams like Iowa and Minn
been established as two of the top
and the emergence of Michigan, O
the past 10 years, the Big Ten look
front of college wrestling for a long
"There's no doubt that the BigI
conference in college wrestling'" M
land said. "The thing is, it's onlyg
the top recruits want to come wres
they know how competitive the c
(the Big Ten) even tougher."
The Big Ten has won every NC
title in the past 10 years. Minnesota
Iowa had taken five straight beforet
Recently, there has been a lot ofd
The biggest surprise this season
which has emerged as a Big Ten tit
made a big statement last weekend
gan to move into second place in th
The Golden Gophers, who have1
two seasons, have looked vulnerabl
Iowa in its first dual meet and ha
Oklahoma State and Iowa again. Ti
er shot at the Hawkeyes this weeken
Iowa has always been the big n
The Hawkeyes have legendary wre
thank for that. Every wrestler know
undefeated throughout college, and
his career. After finishing at Iowa S
Gable went on to win a gold med
process, he crushed the wrestler w
record. Gable was a great wrestl
coach. In his 21-year tenure withI

wrestling leads nation
won 21 Big Ten titles and 15 national titles.
"Coach Gable is a big reason why the Big Ten is the way it
is," McFarland said. "When he was down at Iowa and win-
ure, these conferences are ning all those titles, everyone was trying to be like them."
ball. But when it comes to The Big Ten's strength in wrestling has protected its pro-
been the elite - and it's grams from Title IX - so far. Title IX was implemented to
improve gender equality in collegiate athletics. Wrestling is
esota, which have already among the lower-revenue sports, and has been targeted by
programs in the country, many of the nation's athletic departments affected by Title IX.
)hio State and Illinois over Some of the nation's best wrestlers are without a team to
s poised to be at the fore- wrestle on because of Title IX. The most well known of these
time. talented wrestlers is Stephen Neal - a World and NCAA
Ten is the most dominant champion at Cal-State Bakersfield who now plays guard for
Michigan coach Joe McFar- the New England Patriots. When Cal-State Bakersfield shut
getting better. Every year, down its program, Neal still had eligibility and was the
tle in the Big Ten because favorite to come back and win another national title. Instead,
onference is. That makes Neal, who hadn't played football since high school, joined the
Patriots and was starting by season's end.
CAA Championship team "Title IX has definitely hurt wrestling," McFarland said.
a has won the last two, but "It's just a matter of time until the Big Ten is affected, but
that. right now, it's going strong."
disparity in the Big Ten.

TONY DING/Daily
Sophomore Charlie Henderson (left) is hoping to make an
impact when Michigan head's to East Lansing Saturday.
weekend," Pearson said. "Even though he didn't score, he
added some speed and jump."
Pearson thought Henderson's success was a by-product of
the high pace at which he practices. Sophomore forward Eric
Nystrom agreed.
"The whole season, no matter what, whether he's in the
lineup or out of the lineup, he works his butt off every day
he comes to the rink," Nystrom said. "That's tough to do,
especially when you're out of the lineup and your confi-
dence is down."
With freshman Brandon Kaleniecki questionable for this
weekend's series due to a high ankle sprain, it's possible that
Henderson will be back on the ice against the Spartans. And
if he is, the trip to East Lansing will have been a long time
coming for Henderson.
"Friday night's going to be a big game; I don't want to
look past that. But Saturday will be unbelievable, just
because it's my hometown," Henderson said. "So hopefully
I get a chance to play... there in front of my hometown,
family and friends."

n may be Michigan State,
le contender. The Spartans
, beating Iowa and Michi-
e conference.
been dominant in the past
e of late. Minnesota fell to
s since lost to Iowa State,
he Gophers will get anoth-
id in Iowa City.
ame in college wrestling.
stling coach Dan Gable to
s Gable's story: Gable was
I lost in the final match of
tate with a 182-1 record,
al in the Olympics. In the
iho blemished his college
er, but is an even better
Iowa, the Hawkeyes have

*I

NICOLE I LWILLmIGE/Uaily
Michigan junior Shaun Newton is a big reason for why the Big
Ten has become such a dominant conference.

'Four' tunate pair running wild

By Anne Ulble
For the Daily

NOJe awIR Bch
9br te fie frent fAcne
off you have moderate to evere acne you may qua for
a research study involving new laser technology at the
University of Michigan Department of DermatologyI
oYou may alao receive up to $200 far your par+3 dpatrn
off you are interested In pardticplng. call the University
of Michigan Department of Dermatology to find out more.
o~be nmberis: (734) 764-DM
SUniversity of Michigan
_ Medical Center
.=---a

(9
61 VJ

NOTE

Football T-shirts to
be decided in contest
The athletic department is accepting
designs for a T-shirt to be worn by stu-
dents next season in the Big House.
The deadline for submissions is Friday,
Feb. 21 at 5 p.m. The winner will be
announced in late February.
Submissions are required to be four-
color designs for the front and back of a
maize short-sleeve T-shirt. The winner
will help hold the "Go Blue" banner in
the opener and get two season tickets.
-from Staff Reports.

What can you do in under four min-
utes? Brush your teeth? Eat breakfast
on the go? Michigan track stars Nate
Brannen and Nick Willis can both run
the mile in that time.
Last weekend at the Meyo Invita-
tional at Notre Dame's Loftus Sports
Complex, Brannen and Willis became
the fifth and sixth (respectively) ath-
letes in University of Michigan history
to achieve sub-four minute perform-
ances in the mile. .
Brannen was runner up in the race
with a time of 3:57.96 and Willis
finished fourth with a time of
3:58.15. Both times were not only
NCAA-qualifying times, but also
two of the five world's fastest-mile
times of 2003.
"It was so exciting. The first four
runners were so close together that I
didn't know what place the two boys
came in; only that they were both
within the sub-four minute marker,"

Michigan coach Ron Warhurst said.
For Willis, a freshman from New
Zealand, this was his first time break-
ing four minutes in the mile. But he
has already posted two other NCAA
eligible times in the distance medley
relay and the 3000-meter run..
For Brannen, a sophomore from
Cambridge, Ontario, this was his sec-
ond time running a sub-four minute
mile. Amazingly enough, his first
time was in the summer of his senior
year in high school.
"I played hockey and ran track in
grade school, but in ninth grade I had
to choose running because I knew that
it would hold a better future for me,"
Brannen said.
A well-matched pair, Brannen and
Willis train together, plan out their
races together and room together on
road trips. i
"Nick and I are best friends, on and
off the track," Brannen said.
The two obviously have a bright
future in running at Michigan.
"Willis and Brannen really compli-

ment one another," Warhurst said.
"Together they'll plan out how they
want to race, and during the actual run
they are only out on the track to beat
one another, But, after the event is
over, they'll say 'thanks for getting me
through the race."'
With The Big Ten Championship
nearing (March 1-2), Warhurst would
really like for each runner, thrower and
jumper to achieve his individual best.
The Big Ten is a very competitive
conference for men's track and field
and it is difficult to stay up at the top
with talented teams like Wisconsin
and Minnesota.
"We have a very draining season.
We are in season for nine months out
of the year. Every athlete has to stay
extremely focused," Warhurst said.
This weekend the Wolverines will
head 'off t ocompete at Penn State in
the Sykes-Sabok Challenge Cup Fri-
day and Saturday. (Feb.' 14-15) The
team will take on Big Ten rivals Penn
state and"Ohio State and several
smaller East coast schools.

0

-- I

Contraceptive inj'ection
medroxyprogesterone acetate injectable suspension

3irtk control jou tkirvk aeouxt just +4-x

a year


DEPO-PROVERA* Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely for pregnancy to occur
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a
Iong-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (I3 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use

" if you have had cancer of the breast
" if you have had a stroke
" if you have or have had blood clots (phlebitis) in your legs
- if you have problems with your liver or liver disease
+ if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
" a family history of breast cancer
" an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
- kidney disease
" irregular or scanty menstrual periods
" high blood pressure
: migraine headaches
- asthma
" epilepsy (convulsions or seizures)
" diabetes or a family history of diabetes
= a history of depression
* if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
-injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about I5 months; and about 93% of those who become
pregnant will do so in about 18 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how long it takes you to become pregnant after you stop using it
What are the risks of using DEPO-PROVERA Contraceptive Injection?
l.lrregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA;
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle.
2.Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in
your bones. This could increase your risk of developing bone fractures. The rate of bone mineral
loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the
normal rate of age-related bone mineral loss.
3ancer
Studies of women who have used different forms of contraception found that women who used
DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the
breast, ovary uterus, cervix, or liver However women under 35 years of age whose first exposure
to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of
developing breast cancer similar to that seen with oral contraceptives. You should discuss this with
your health-care provider.

6.Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
- sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
" sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
- severe pain or swelling in the calf (indicating a possible clot in the leg)
* unusually heavy vaginal bleeding
. severe pain or tenderness in the lower abdominal area
-persistent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
. Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year: Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2. Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility deep vein
thrombosis, pulmonary embolus, breast cancer; or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
I.Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely. If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. However; if you think
that you may be pregnant, see your health-care provider:
2.Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as
DEPO-PROVERA.
3.Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
4.Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful
effects have been found in these children. DEPO-PROVERA does not prevent the breasts from
producing milk, so it can be used by nursing mothers. However; to minimize the amount of
DEPO-PROVERA that is passed to the infant in the first weeks after birth, you should wait until
6 weeks after childbirth before you start using DEPO-PROVERA for contraception.
How often do I get my shot of DEPO-PROVERA Contraceptive Injection?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a
single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant
at the time of the first injection, it is essential that the injection be given ONLY during the first
5 days of a normal menstrual period, If used following the delivery of a child, the first inlection of

#I

Lowest
Method Expected Typical
DEPO-PROVERA 0.3 0.3
Implants (Norplant) 0.2* 0.2*
Female sterilization 0.2 0.4
Male sterilization 0.1 0.15
Oral contraceptive (pill) 3
Combined 0.1
Progestogen only 0.5-
IUD 3
Progestasert 2.0 -
CopperT 380A 0.8 -
Condom (without spermicide) 2 12
Diaphragm (with spermicide) 6 18
Cervical cap 6 18
Withdrawal 4 I8
Periodic abstinence 1-9 20
Spermicide alone 3 21